Company: GIFLF
Filing Date: 2025-02-26
Form Type: 6-K
Source: 0001104659-25-017501
Chunk: 8

Company: Grifols SA
Filing Date: 2025-02-26
Form: 6-K
Chunk 8
---
 debt refinancing • Enhanced liquidity through RCF extension and cash flow generation G overnance and leadership team • Strengthened governance with changes at Board of Director level, including 3 new appointments • Additions to the leadership team in key positions

- 6 - Q4 2024 Results Introductory Remarks Business Performance Financials Final remarks Annex Note: All figures are presented on a consolidated basis (including Biotest), and at constant currency (cc), excluding exchang e r ate fluctuations over the period. See Annex for reconciliations. 1 FCF definition and reconciliation to the Cash Flow Statement in slide 39 in the Annex ; 2 Leverage ratio defined as per the Credit Agreement in slide 36 in the Annex Revenue EBITDA Adj. Free Cash Flow pre - M&A 1 Leverage ratio 2 Q4’24 FY24 Opening Remarks Delivering on Guidance for the Year €7,212m +10.3% cc €1,779m Margin 24.7% €266m +€442m vs. FY23 €1,976m +13.6% cc €526m Margin 26.6% €335m +€326m vs. Q4’23 Leverage ratio 2 4.6x

- 7 - Q4 2024 Results 6,592 7,271 1 2 3 4 5 6 7 Note: All figures are presented on a consolidated basis (including Biotest), and at constant currency (cc), excluding exchang e r ate fluctuations over the period. See Annex for reconciliations. 1 Underlying growth excluding one - off in Q1’23 revenues related to a €19m commercial true - up in Diagnostic; 2 Blood Typing Solutions (BTS); 3 Molecular Donor Screening (MDS) 7,212 FY ’23 Biopharma Diagnostic Bio Supplies and others FY ’24 CC FX YTD Q4’24 629 14 63 Revenues (in million EUR) +10.3% +9.4% 59 • Global underlying demand across relevant indications • IVIG momentum across geographies • SCIG penetration continues to expand • Building on alliance with SRAAS in China Biopharma +15.1% Q4’24 + 11.3% FY ’24 • Strong market position in BTS 2 and MDS 3 businesses • Increased blood and plasma donations • Broad geographic demand across all relevant